Nontraumatic intracerebral hemorrhage, unspecified. I61.9 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2019 edition of ICD-10-CM I61.9 became effective on October 1, 2018.
Full Answer
The new codes are for describing the infusion of tixagevimab and cilgavimab monoclonal antibody (code XW023X7), and the infusion of other new technology monoclonal antibody (code XW023Y7).
ICD-10-CM Diagnosis Codes
A00.0 | B99.9 | 1. Certain infectious and parasitic dise ... |
C00.0 | D49.9 | 2. Neoplasms (C00-D49) |
D50.0 | D89.9 | 3. Diseases of the blood and blood-formi ... |
E00.0 | E89.89 | 4. Endocrine, nutritional and metabolic ... |
F01.50 | F99 | 5. Mental, Behavioral and Neurodevelopme ... |
Search the full ICD-10 catalog by:
The 2022 edition of ICD-10-CM I69.198 became effective on October 1, 2021.
Category I69 is to be used to indicate conditions in I60 - I67 as the cause of sequelae. The 'sequelae' include conditions specified as such or as residuals which may occur at any time after the onset of the causal condition. Type 1 Excludes.